000 01522 a2200421 4500
005 20250513115512.0
264 0 _c19970724
008 199707s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/s0014-2999(97)00060-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKovács, K J
245 0 0 _aZn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cApr 1997
300 _a117-23 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aBinding, Competitive
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDizocilpine Maleate
_xmetabolism
650 0 4 _aDrug Interactions
650 0 4 _aExcitatory Amino Acid Antagonists
_xmetabolism
650 0 4 _aGlutamic Acid
_xmetabolism
650 0 4 _aGlycine
_xmetabolism
650 0 4 _aIsotope Labeling
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPentazocine
_xmetabolism
650 0 4 _aRadioligand Assay
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xantagonists & inhibitors
650 0 4 _aSpinal Cord
_xdrug effects
650 0 4 _aTritium
650 0 4 _aZinc
_xpharmacology
700 1 _aLarson, A A
773 0 _tEuropean journal of pharmacology
_gvol. 324
_gno. 1
_gp. 117-23
856 4 0 _uhttps://doi.org/10.1016/s0014-2999(97)00060-5
_zAvailable from publisher's website
999 _c9119350
_d9119350